152 related articles for article (PubMed ID: 30893604)
21. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
22. DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.
Basu S; Barad M; Yadav D; Nandy A; Mukherjee B; Sarkar J; Chakrabarti P; Mukhopadhyay S; Biswas D
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6509-6520. PubMed ID: 32152128
[TBL] [Abstract][Full Text] [Related]
23. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
[TBL] [Abstract][Full Text] [Related]
24. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
26. Binding and modulation of p53 by p300/CBP coactivators.
Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
[TBL] [Abstract][Full Text] [Related]
27. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2.
Hofmann TG; Möller A; Sirma H; Zentgraf H; Taya Y; Dröge W; Will H; Schmitz ML
Nat Cell Biol; 2002 Jan; 4(1):1-10. PubMed ID: 11740489
[TBL] [Abstract][Full Text] [Related]
28. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
29. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
[TBL] [Abstract][Full Text] [Related]
30. Deleted in breast cancer 1 (DBC1) deficiency results in apoptosis of breast cancer cells through impaired responses to UV-induced DNA damage.
Kim W; Kim JE
Cancer Lett; 2013 Jun; 333(2):180-6. PubMed ID: 23352644
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
Liu Q; Luo Q; Feng J; Zhao Y; Ma B; Cheng H; Zhao T; Lei H; Mu C; Chen L; Meng Y; Zhang J; Long Y; Su J; Chen G; Li Y; Hu G; Liao X; Chen Q; Zhu Y
Elife; 2022 Aug; 11():. PubMed ID: 35913115
[TBL] [Abstract][Full Text] [Related]
32. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
[TBL] [Abstract][Full Text] [Related]
33. The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression.
Giguère SS; Guise AJ; Jean Beltran PM; Joshi PM; Greco TM; Quach OL; Kong J; Cristea IM
Mol Cell Proteomics; 2016 Mar; 15(3):791-809. PubMed ID: 26657080
[TBL] [Abstract][Full Text] [Related]
34. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.
Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H
Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890
[TBL] [Abstract][Full Text] [Related]
35. Sumoylation controls CLOCK-BMAL1-mediated clock resetting via CBP recruitment in nuclear transcriptional foci.
Lee Y; Chun SK; Kim K
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2697-708. PubMed ID: 26164627
[TBL] [Abstract][Full Text] [Related]
36. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
[TBL] [Abstract][Full Text] [Related]
37. TNFalpha induces acetylation of p53 but attenuates its transcriptional activation in rheumatoid synoviocytes.
Nakazawa M; Aratani S; Hatta M; Araya N; Daitoku H; Kawahara K; Watanabe S; Nakamura H; Yoshino S; Fujii R; Fujita H; Fukamizu A; Nishioka K; Nakajima T
Int J Mol Med; 2002 Sep; 10(3):269-75. PubMed ID: 12165799
[TBL] [Abstract][Full Text] [Related]
38. Interaction of DBC1 with polyoma small T antigen promotes its degradation and negatively regulates tumorigenesis.
Sarwar Z; Nabi N; Bhat SA; Gillani SQ; Reshi I; Un Nisa M; Adelmant G; A Marto J; Andrabi S
J Biol Chem; 2022 Feb; 298(2):101496. PubMed ID: 34921839
[TBL] [Abstract][Full Text] [Related]
39. DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
Moon SJ; Jeong BC; Kim HJ; Lim JE; Kwon GY; Kim JH
Oncogene; 2018 Mar; 37(10):1326-1339. PubMed ID: 29249800
[TBL] [Abstract][Full Text] [Related]
40. TRIM25 has a dual function in the p53/Mdm2 circuit.
Zhang P; Elabd S; Hammer S; Solozobova V; Yan H; Bartel F; Inoue S; Henrich T; Wittbrodt J; Loosli F; Davidson G; Blattner C
Oncogene; 2015 Nov; 34(46):5729-38. PubMed ID: 25728675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
